Johnathan Q. Trinh, MD, et al discuss a novel case of a patient with an aggressive CDKN2A-mutated spiradenocarcinoma who responded to a CDK4/6 inhibitor.
Jonathan Q. Trinh, MD
Advertisement
Articles by Jonathan Q. Trinh, MD
Advertisement
Latest Updated Articles
A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A MutationPublished: June 12th 2024 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Novel Blood-Based Prostate Cancer Test for Elevated PSA Levels
2
FDA Grants Fast Track Designation to Novel FLT3/CD3 Bispecific in R/R AML
3
Zanidatamab Shows Meaningful Benefit in HER2+ Biliary Tract Cancer
4
JANX007 Displays Encouraging Safety/Efficacy in Metastatic CRPC
5
